Skip to main content

Animations

MJFF Publications

4801 - 4810 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2023
  • 2023
  • 2017
  • 2025
  • 2016
  • 2022
  • 2024
  • 2014
  • Summary Details
    OPEN
    Title: Mapping typical and hypokinetic dysarthric speech production network using a connected speech paradigm in functional MRI
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2020.102285
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13386
    Citation Count: 29
  • Summary Details
    OPEN
    Title: A blood-based marker of mitochondrial DNA damage in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1557
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.14123
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Hypoxic conditioning in Parkinson’s disease: randomized controlled multiple N-of-1 trials
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-025-63324-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2015.00089
    Citation Count: 59
  • Summary Details
    OPEN
    Title: A connectomics-based taxonomy of mammals
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.78635
    Citation Count: 25
  • Summary Details
    OPEN
    Title: TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cell.2024.05.030
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2014.10.079
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.